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Aims: To study the short- and long-term results of pulmonary rehabilitation (PR) given in the 
Helsinki University Heart and Lung Center and to understand the hospital resources used to 
treat severe COPD exacerbations in the city of Helsinki.
Materials and methods: Seventy-eight inactive patients with severe COPD were recruited for 
a PR course; three of them did not finish the course. The course took 6–8 weeks and included 
11–16 supervised exercise sessions. Using electronic medical records, we studied all COPD 
patients with hospital admission in the city of Helsinki in 2014, including COPD diagnosis, 
criteria for exacerbation, and potential exclusion/inclusion criteria for PR.
Results: Seventy-five of the patients finished the PR course and 92% of those patients showed 
clinically significant improvement. Their hospital days were reduced by 54% when compared 
to the year before. At 1 year after the course, 53% of the patients reported that they have con-
tinued with regular exercise training. In the city of Helsinki, 437 COPD patients were treated 
in a hospital due to exacerbation during 2014. On the basis of their electronic medical records, 
57% of them would be suitable for PR. According to a rough estimate, 10%–20% hospital days 
could be saved annually if PR was available to all, assuming that the PR results would be as 
good as those shown here.
Conclusions: The study showed that in a real-world setting, PR is efficient when measured 
by saved hospital days in severe COPD. Half of the patients could be motivated to continue 
exercising on their own.
Keywords: COPD, severe exacerbation, pulmonary rehabilitation, physical inactivity, COPD 
health care costs
Introduction
COPD is a major health problem, but goes often unrecognized until moderate to 
severe disease progression.1,2 The main symptom is dyspnea, which limits the patient’s 
physical activity.3–6 Another feature is exacerbations, the periods of worsening dys-
pnea which are often associated with increasing mucus production and respiratory 
infections.7,8 Exercise-based pulmonary rehabilitation (PR) in randomized controlled 
trials has proven to reduce exacerbations, subjective dyspnea, and the need for 
re-hospitalization.4,9 However, meta-analysis of 20 studies (1,477 participants) showed a 
great variation in PR programs, including patients’ self-management. Eight of the stud-
ies involving 810 participants indicated that PR reduced hospital readmissions (pooled 
odds ratio 0.44, 95% confidence interval 0.21 to 0.91), but results showed significant 
heterogeneity compared to each other.10 Presently, the essential components of PR 
needed to successfully induce long-term physical activity are poorly understood.
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In Finland, public health care is of high quality and equally 
available for all citizens. Like in the other Nordic countries, 
the health benefits of exercising are well understood. There are 
more active trainers in Finland, for example, than in Southern 
Europe.11 Despite this fact and the recommendations of the 
international and national guidelines, exercise-based PR has not 
yet become well-recognized standard of care of COPD.12
Standardized group PR interventions as part of the usual 
care in severe COPD were started at the Helsinki University 
Hospital Heart and Lung Center in the year 2010. In this 
PR approach, we had two objectives: first, to improve the 
patients’ physical performance, and second, to encourage the 
patients to find new exercise activities and continue training 
after the course was completed. Retrospectively, we studied 
whether we succeeded in these goals and were able to observe 
a reduction in their hospital days during the following year. 
We also wanted to have a better understanding of the hospital 
resources used to treat COPD exacerbations in the city of 
Helsinki (having population of 620,000) and estimate what 
level of reduction could be achieved if PR was equally avail-
able to patients suffering from COPD exacerbations.
Materials and methods
Patients selected for Pr
All the patients were recruited from the Helsinki University 
Hospital Heart and Lung Center, during the years 2010–2015. 
Exclusion criteria for PR were dementia, alcohol or drug 
abuse, multimorbidity, neurological or musculoskeletal disor-
der, psychiatric condition, active cancer, poor communication 
skills or adherence to care, and unstable cardiovascular or 
severe peripheral vascular disease. Patients were excluded 
based on these reasons, only if the exercise-prohibiting 
disease was severe or the lack of co-operation was obvious. 
Smokers were not excluded. All patients were enrolled to the 
PR group by one pulmonary consultant (MK).
Pulmonary rehabilitation course
The PR course was structured according to the international 
guidelines.13 The multidisciplinary team consisted of a phys-
iotherapist, a pulmonary nurse, a pulmonary consultant, and a 
nutritional therapist. After the 6-week pilot with 5 patients, the 
course lasted 8 weeks, and the number of supervised exercise 
sessions varied from 11 to 16. The 1 h and 45 min exercise 
session was conducted twice a week and consisted of aerobic 
and muscle strength training for upper and lower extremities. 
The participants were also advised to exercise at least once a 
week on their own. PR was conducted at only one location, and 
every visit costs 8–9€ plus the costs of transportation. If the 
patient was not able to use his own car or the public trans-
portation, the taxi was reimbursed, the patients’ share being 
16€ one way. When patients’ performance was tested at the 
end of the course and compared to the results at the beginning 
of the course, the change was considered clinically meaning-
ful (minimal clinical importance difference) when walking 
distance in the 6-minute walking test (6MWT) improved 
by 35 m, the chair sit-up test by 1.7 s, or the COPD assess-
ment test (CAT) questionnaire symptom score decreased by 
2 points.14–16 The PR course also included an educational 
lecture by a nutritional therapist and a motivational speech by 
a pulmonary consultant (MK). Help with smoking cessation 
was offered for smokers. The patients were interviewed by 
a physiotherapist on their individual testing visit before the 
start of the group training. They answered questions about 
their exercise habits and performance status. At the end of the 
course, all the participants prepared an individual exercise plan 
with the help of a physiotherapist. Independent training was 
encouraged by the COPD nurse and physiotherapists, and help 
was offered to find a place to exercise after the course. The 
information about their activity and exercise habits at 1 year 
were evaluated using the electronic medical records (eMR).
To understand the hospital resources needed to treat 
COPD exacerbations in the city of Helsinki, we evalu-
ated all hospital admissions with COPD (ICD10 code J44) 
listed among the discharge diagnoses in 2014. A single 
consultant in pulmonary medicine (MK) evaluated the 
diagnostic criteria and all hospital treatment periods for 
the next 12 months or until death using eMR. The diagnosis 
of COPD was confirmed on the basis of clinical history of 
the disease, smoking history, and FEV
1
/FVC (forced expira-
tory volume in 1 s/forced vital capacity) ratio ,0.7 in the 
latest spirometry. When spirometry results were lacking, the 
diagnosis was confirmed by the author by consistent clinical 
signs and symptoms, use of COPD medication, and smoking 
history. The criteria for COPD exacerbation was documented 
dyspnea or obstructive breathing, use of short/long-acting 
bronchodilators, oral or intravenous corticosteroids, and 
possibly antibiotics during the hospital stay.
Both of these registry-based study designs were approved by 
the Office of the Data Protection Ombudsman, Finland, and the 
data gathering and analysis were performed with the permission 
of the Helsinki City and the Helsinki University hospitals.
statistics
Statistical analyses were performed using SPSS, and the 
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effectiveness of Pr for reduction of COPD exacerbations
Results
Pulmonary rehabilitation group
All patients (N=78) who were enrolled in PR had severe or 
very severe COPD (Table 1). All of them were physically 
inactive. The mean 6MWT result was 328 m (SD 128), the 
mean chair sit-up test result was 18.7 s (SD 9.4), and the 
mean CAT-score was 20 (SD 6). Despite optimized medica-
tion, they had unstable disease with the tendency of frequent 
exacerbations. Six of them were evaluated for organ trans-
plant. One patient left the course due to lack of motivation, 
and two left due to severe exacerbation. The majority (N=45, 
58%) of patients were recruited during or after hospital stay 
due to COPD exacerbation.
To study the efficacy of the PR course, we performed the 
6MWT, the chair sit-up tests, and CAT-questionnaire and 
analyzed the symptom scores before and after the course. 
Sixty-nine patients (92%) were successful reaching MCID 
or higher in at least one measurement.
When patients were evaluated 1 year after PR, 40 (59%) 
of the living 68 patients reported that they had continued 
exercising. Of those six patients, who did not reach MCID by 
any of the measurements, four reported exercising regularly 
at 1 year. They had found new places to exercise, often senior 
gyms or group gymnastics. Active trainers did not differ by 
gender, age, body mass index (BMI), lung function, or by need 
of ventilation support from the patients who did not continue 
training. The only significant difference was the higher number 
of smokers among patients who did not keep their exercise 
habits when compared to active trainers (11/34 vs 2/40).
Hospital admissions and hospital days during the emer-
gency visits were compared 1 year before and after the PR 
course, and the results showed significant reduction (Table 2). 
Seven patients died during the follow-up. If these patients 
were excluded from the analysis the result was almost the 
same as without their inclusion in the analysis; the trends 
between findings before and after remained similar and sig-
nificant (8.4 hospital days before vs 3.3 days after, p=0.016). 
Data suggested that the best PR results were reached among 
women, patients under 70 years of age, and patients who 
remained active at 1 year, but the observed differences were 
not statistically significant (data not shown).
severe COPD exacerbations in helsinki
We identified a total of 935 patients who were discharged 
in the year 2014 with the diagnosis of ICD10: J44 (COPD). 
Of these 935 patients, we were not able to find any firm signs 
of COPD for 116 in their eMR. Further, 382 of them were 
COPD patients, but the hospitalization was due to causes 
other than COPD. The remaining 437 patients were verified as 
having COPD with acute exacerbation, and they were included 
in the analysis (Table 3). Starting from discharge, in total, 
these patients suffered 478 hospital-treated exacerbations 
(4,210 hospital days) during the follow-up year. Compared 
to the PR group, these patients were on average 7 years 
older. Their mean length of hospital stay was 14.0 days, the 
90-day readmission rate was 27%, and the 90-day mortality 
rate was 12.9%. Patients in both cohorts suffered from severe 
airway obstruction, but death rate was significantly lower 
in the PR cohort (7/78=9.0% vs 157/437=36.0%, p=0.004) 
during the follow-up year (Table 4). Twenty-four (5%) 
patients died on the first admission, thus altogether 41% of 
the patients died during the 1-year period.
We analyzed how many patients would be suitable for 
PR under the same criteria as used in the PR protocol. Based 
on the evaluation of their eMRs, 57% of the patients were 
shown be fit for PR (Table 3). With the exception of male 
gender, the suitable and unsuitable patients did not differ 
from each other. Table 4 shows the hospital admissions and 
prognosis of these patients.
In the PR group, we found a reduction of 54% in hospital 
days (420/782) during the year after PR compared to the 
Table 1 Characteristics of the patients who finished the PR 
course and the subgroup of patients who showed active exercise 





Patients with active 
exercise habits
1 year after PR,
N=40
Mean age (sD) 67 (7.9) 67 (9.0)
Male 45 (60%) 23 (58%)
Mean BMI (sD) 25 (6.2) 24 (0.5)
Mean FeV1% from expected (sD) 36 (14.3)
a 39 (34.7)a
Mean FVC% from expected (sD) 70 (20.1)a 68 (19.7)a
Mean diffusion capacity % from 
expected (sD)
42 (15.3)b 42 (15.3)b
Using lTOT 14 (19%) 4 (10%)








Death during the follow-up year 7 (10%)
at least one hospital admission 
during the year before Pr
43 (57%) 35 (86%)
at least one emergency visit 
during the year before Pr
43 (57%) 27 (68%)
Notes: anot available for 1 patient; bnot available for 31 patients; cp=0.01 in comp-
arison with the proportion of smokers in the whole study group and in patients 
remaining active after 1 year.
Abbreviations: BMI, body mass index; FeV1, forced expiratory volume in 1 s; 
FVC, forced vital capacity; lTOT, long-term oxygen therapy; nIV, noninvasive 
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year before. With similarly organized systematic PR for all 
COPD patients after hospital-treated exacerbation, we can 
roughly estimate the potential reduction of hospital days, 
assuming that the PR results are as good as in pulmonary 
clinic. Thus, patients who were not suitable for PR (47%) 
had 2,092 hospital days in total, and in that cohort no 
reduction would be achieved. Suitable patients (53%) had 
2,118 hospital days. If we assume that half of the patients 
are adherent to PR, and the result of PR would be similar, 
we could achieve 10%–20% decline in hospital utilization 
due to severe exacerbations.
Discussion
The present study showed a significant reduction in 
hospital admissions among COPD patients with exacerba-
tion, achieved with PR in a real-world setting. We showed 
clinically improved performance and/or reduced symptoms 
in 92% of patients after PR. We also showed a reduction of 
54% in hospital days during the following year which was 
comparable to that reported before.17 Moreover, at 1 year, 
59% of the patients surviving the follow-up year reported 
that they had continued regular training after the PR course. 
Their results in the reduction of severe exacerbations showed 
even better trends than among the rest of the patients, but 
the differences were not statistically significant.
To put the effectiveness of PR into context, we also 
analyzed the hospital resources used to treat COPD exac-
erbations in the city of Helsinki. Using eMRs, we carefully 
studied all hospital treatment periods for COPD exacerba-
tions in 1 year and estimated the proportion of the patients 
suitable for PR and thus, the potential benefits of PR. Using 
the same inclusion and exclusion criteria as in the PR course 
of the Heart and Lung Center, more than half of the hospital-
treated COPD patients were found suitable for PR. By 
using a very simplistic model, we estimated that 10%–20% 
of hospital days could be reduced by offering PR to all 
suitable patients. Severity of obstruction, age, and gender 
did not predict the suitability or success of continuation of 
training independently.
The estimate of saved hospital days should be interpreted 
with caution, and most probably, it might be too optimistic. 
In a review published in 2014, the finding was that the adher-
ence to PR is about the same as to medication, that is, 50%.18 
COPD patients’ socioeconomic status is often low, and the 
expenses of the pulmonary clinic’s PR course, including the 
rather high transportation costs (varying up to 440–640€ 
if taxi or invalid taxi was needed), might be a meaningful 
limitation for participation.19 To lower the expenses and 
assure the availability for everyone, the PR courses and the 
personalized training activities should be organized at several 
Table 2 hospital admissions 1 year before and after Pr among 75 Pr patients and the subgroup of patients who had maintained their 
exercise activity
Severe exacerbations and mortality During the year  
before PR, all (N=75)
During the year  
after PR, all (N=75) 
During 1 year after PR 
with active exercise habits
Mean emergency visits per patient (sD) 1.1 (1.3) 0.6 (1.1) 0.5 (1.0)
Mean hospital admissions per patient (sD) 0.9 (1.2) 0.6 (1.0)* 0.43 (0.84)
Mean hospital days per patient (sD) 10.4 (20.8) 4.8 (12.2)** 3.85 (9.3)
hospital days in total 782 362 150
Death during follow-up 7 (9%)
Notes: *p,0.001; **p,0.001.
Abbreviation: Pr, pulmonary rehabilitation.
Table 3 Characteristics of the helsinki COPD patients who 
were admitted in the year 2014 due to severe exacerbation in any 
of the hospitals in the area according to their suitability for Pr
Characteristics COPD patients admitted 
due to severe exacerbation 





Patients n=250 (57%) n=187 (43%)
Males in the cohort 143 (57%) 91 (49%)a
Mean age (sD) 74 (8.0) 74 (11.1)
FeV1% from expected, mean (sD)
b 43.9 (14.8) 41.4 (15.6)
FVC% from expected, mean (sD)c 71.3 (17.5) 74.8 (89.2)
restrictions for Pr, n (%)
Dementia 36 (18)
alcohol or drug abuse 35 (18)
Multimorbidity 25 (13)
neurological or musculoskeletal 
disorder
24 (12)
Psychiatric condition 23 (12)
Death during the reference 
admission
21 (11)
active cancer 13 (7)
Poor communication skills or 
adherence to care
8 (4)
Unstable cardiovascular or severe 
peripheral vascular disease
2 (4)
Notes: ap=0.04; b87 and c99 spirometry results were not available. For these 
patients, the diagnosis of COPD was confirmed on the basis of clinical findings.
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effectiveness of Pr for reduction of COPD exacerbations
sites closer to the patients’ homes. The participants of the PR 
group of the Heart and Lung Center were obviously highly 
motivated to finish the course. They were also younger than 
patients treated for exacerbating COPD at large. However, 
in the PR group age, gender, or lung function did not predict 
the PR outcome. The high mortality among the hospital-
treated COPD patients suggests that other causes such as 
comorbidities, poor social networks, and possibly cognitive 
skills most likely decrease the success rate of PR. COPD 
patients suffer from multimorbidity.20,21 It was not a surprise 
that almost half of the COPD patients’ hospital admissions 
were due to reasons other than exacerbations. Therefore, it 
is also possible that registry-based studies without access 
to eMRs may overestimate the burden of hospital-treated 
COPD exacerbations.
It has been estimated that 10,000 Finns have very severe 
COPD.22 Approximately 1,000 of them live in Helsinki. 
Our results show that almost half of them needed hospital 
care because of an exacerbation during 1 year. According 
to previous Finnish study, the average length of hospital 
stay decreased from 16.4 to 9.6 days during 1972–1992.23 
Based on the present study, we did not find further positive 
development in the Helsinki area. The mortality rate of 
41% in a year among the hospital-treated exacerbating 
COPD patients was high. The European COPD audit results 
from 422 hospitals in 13 countries showed that the median 
hospital stay was 8 vs 14 days in our study in Helsinki, the 
90-day readmission rate was 35.1% vs 27.2%, and the 90-day 
mortality rate of 6.1% was lower than our rate of 12.9%. 
However, according to the European audit results, 80% of 
the exacerbating COPD patients were at least partly cared for 
by pulmonologists, compared to only 26% in Helsinki.24 The 
longer mean hospital stay is probably explained by the fact 
that, in Helsinki, patients who are unable to manage at home 
anymore, often have to wait in hospital wards for a place at a 
senior home or other assisted living accommodation.
Multiple PR studies have reported that the improve-
ment in patients’ exercise capacity and physical activity 
decreased gradually during a year after PR.19,25,26 Therefore, 
from the first day, we concentrated on encouraging the 
patients to exercise independently and taught them during 
the supervised session that exercising is safe. We had pre-
viously learned that, due to cold winters, the patients also 
need an indoor exercising activity to be active year round.6 
Together, the physiotherapist and participants developed a 
personalized training program. They also searched for suit-
able training facilities and, when possible, the PR participants 
were encouraged to continue training together. Using this 
approach, we could promote sustainable exercise habits to 
half of the patients, suggesting that this might aid in achieving 
better and longer lasting results. This finding was in line with 
a recent study in which 28 COPD patients were evaluated 
1 year after 10 weeks of PR. These patients did not have any 
specific follow-up program, but they were given an exercise 
prescription to follow. Thirty-nine percent of the participants 
reported continuing self-directed exercising, and repeated 
measures confirmed not only improved functional capacity, 
but also improved cognitive performance and psychological 
well-being.27 When considering that COPD is a progressive 
disease, this result is even more convincing.
Conclusion
On the basis of the present results, almost 40% of the 
COPD patients died during the following year after severe, 
hospital-treated exacerbation. Therefore, a severe exacer-
bation should always be considered as a potentially life-
threatening complication of COPD. In addition to optimizing 
medication, the patients should be offered help with smoking 
cessation, information about the benefits of exercising, 
and easy access to PR. From the beginning, the PR course 
should aim to support the development of long-lasting, per-
sonalized exercise habits for each patient. Our study also 




Suitable for PR, 
N=232 (53%)
Unsuitable for PR, 
N=205 (47%)
at least one hospital admission during the follow-up year, n (%) 219 (50%) 117 (50%) 102 (50%)
Mean number of hospital admissions per patient (sD) 1.09 (1.71) 1.0 (1.5) 1.2 (1.9)
Mean number of hospital days (sD) 9.7 (17.0) 8.8 (16.0) 10.7 (18.0)
Mean number of days until the second admission (sD) 99.7 (94.3) 109.1 (100.9) 88.2 (84.7)
Death during the follow-up period, n (%) 157 (36%) 75 (32%) 82 (40%)
Mean number of days until death (sD) 120.2 (111.4) 137.4 (112.3) 104.5 (108.1)
Mean age at death (sD) 77 (8.5) 77 (6.2) 78 (10.1)
hospital admissions in total 477 239 238
hospital days in total 4,210 2,118 2,092
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implied that offering PR after severe exacerbations may 
provide savings in health care expenses.
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